Can you give us some names, I don’t want to sign up.
They include blockbusters like Merck's Cozaar and Novartis's Diovan, but much of the data in the new analysis was from use of the drug telmisartan, sold under the brand Micardis by Boehringer Ingelheim.
Thank is all the article gave. But, I believe that they are saying the entire class of drugs may increase cancer risk. Now, as I do a google search, there apparently is another study that suggests it may inhibit cancer risk (the opposite).
atacand blood pressure medication - Google Search
and then scroll down to the bottom where there are links to the meds I see posted on this thread.
A lot of times the ending of the name of the drug gives you a clue as to what class of drugs it is. I would imagine that any drug that ends with “sartan” or “artan” is an ARB.
It’s a guess, but I’ve usually found it to be true.
The problem is that we are all taking way too many drugs in a futile quest to achieve what the doctors have decreed to be the perfect number. Sometimes it takes years for the serious side effects of a drug to surface. Personally, I would not take any drug that has not been on the market for less than 10 years.